Gene · 5771
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Review: microbial metabolites - a key to address gut inflammation and barrier dysfunction in the premature infant. | Gut Microbes | 2025 | 40887742 | PubTator, text mining | PubMed |
| Splicing QTL mapping in stimulated macrophages associates low-usage splice junctions with immune-mediated disease risk. | Nat Commun | 2025 | 40866368 | PubTator, text mining | PubMed |
| Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriers. | Nat Commun | 2025 | 40858599 | PubTator, text mining | PubMed |
| Integrative molecular network analysis of genetic risk factors to infer biomarkers and therapeutic targets for rheumatoid arthritis. | PLoS One | 2025 | 40839671 | PubTator, text mining | PubMed |
| First the B cells fall, then the T cells follow: temporal immunological shift with ocrelizumab in multiple sclerosis. | J Neurol | 2025 | 40819018 | PubTator, text mining | PubMed |
| Prdm12 governs an epigenetic checkpoint linking neuroimmune cross-talk to CD8+ T cell exhaustion-suppressed antitumor immunity. | Sci Adv | 2025 | 40815657 | PubTator, text mining | PubMed |
| The phosphatases TCPTP, PTPN22, and SHP1 play unique roles in T cell phosphotyrosine maintenance and feedback regulation of the TCR. | Sci Rep | 2025 | 40739316 | PubTator, text mining | PubMed |
| PTPN2 Inhibition Disrupts Mitochondrial Renewal and Blocks TFRC-Mediated Mitophagy to Exert Anti-Tumor Activities in ALK-Positive Anaplastic Large Cell Lymphoma. | Adv Sci (Weinh) | 2025 | 40734623 | PubTator, text mining | PubMed |
| Silencing PTPN2 with nanoparticle-delivered small interfering RNA remodels tumor microenvironment to sensitize immunotherapy in hepatocellular carcinoma. | Acta Pharm Sin B | 2025 | 40654369 | PubTator, text mining | PubMed |
| The PTPN2 rs1893217 IBD risk allele increases susceptibility to AIEC invasion by a JAK-STAT-CEACAM6 axis. | Gut Microbes | 2025 | 40624731 | PubTator, text mining | PubMed |
| The tumor promoter 12-O-tetradecanoylphorbol-13-acetate suppresses cell proliferation in metastatic melanoma through TC-PTP/PTPN2 and SH-PTP2/PTPN11. | J Biochem | 2025 | 40590096 | PubTator, text mining | PubMed |
| Rag2Mol: structure-based drug design based on retrieval augmented generation. | Brief Bioinform | 2025 | 40501069 | PubTator, text mining | PubMed |
| PTPN2 inhibits TG-induced ERS-initiated TNBC apoptosis through the mitochondrial pathway. | Sci Rep | 2025 | 40481083 | PubTator, text mining | PubMed |
| Insights into PTP1B inhibitors as antidiabetic agents: Current research and future perspectives. | Eur J Med Chem | 2025 | 40460723 | PubTator, text mining | PubMed |
| PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking Azathioprine. | Clin Transl Sci | 2025 | 40442974 | PubTator, text mining | PubMed |
| PTPN2: Advances and perspectives in cancer treatment potential and inhibitor research. | Int J Biol Macromol | 2025 | 40441553 | PubTator, text mining | PubMed |
| TCPTP inhibition as a novel therapeutic strategy for esophageal squamous cell carcinoma: discovery and efficacy of COH29. | Biochem Pharmacol | 2025 | 40414512 | PubTator, text mining | PubMed |
| Bioinformatics analysis reveals shared molecular pathways for relationship between ulcerative colitis and primary sclerosing cholangitis. | Genomics Inform | 2025 | 40375266 | PubTator, text mining | PubMed |
| Traditional Chinese medicine for sepsis: advancing from evidence to innovative drug discovery. | Crit Care | 2025 | 40375087 | PubTator, text mining | PubMed |
| PTPN2 Negatively Regulates Macrophage Immune Responses and Cellular Bioenergetics. | FASEB J | 2025 | 40344246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5771/papers?page=4